Wednesday, 23 August 2017

Optibiotix back in profit!

Oh happy day!

Mainly thanks to sinking most of my IQE:IQE profits into OPTI:Optibiotix at just under 60p last week, today's rise of the bid price by 4p to 69p has changed what was a £4,500 paper loss a few weeks ago into a £516 profit today.

My SIPP holding received all the new shares and now stands at 21,458 with an average cost of 64.64p. These are making £837 potential profit.

My share account holding is just 2,044 shares with an average price of 65.89p and making £42 profit. I want to transfer these to my ISA but daren't in case it invalidates any free SBTX:Skinbiotherapeutics shares if the qualification date is back-dated.

My ISA is letting the side down, with 20,458 shares at an average price of 70.28p. These are still losing £363 - but for how much longer?

So although the last few years, and most especially the last few weeks, have been very trying and frustrating, they have done me a massive favour, as I've been able to accumulate a ridiculous amount of shares that I wouldn't have even considered if the price had sneaked up gradually. IQE:IQE is a perfect example - I know I should have been buying more, but as the price kept going up I found excuses not to - or at least decided OPTI:Optibiotix was better value when the price dipped.

As a result of that accumulation, the potential here is exponentially more than it would have been had the price behaved more rationally.

Yesterday's announcement of the enhanced deal with SACCO was stunning. Not only does it open up the American market which is surely a prerequisite for any deals with a multinational, but it opens up the dairy market. Probiotic yogurts are massive, but health claims are a bit wishy-washy. Get LP-LDL in there and open up real tangible health benefits.

I really hope this time my holding stays in profit and we can maintain at least 70p until the news of big contracts is released.

At the mid-week point my portfolio is looking very healthy. The timing of the IQE:IQE sale was perfect for both OPTI:Optibiotix and CAML:Central Asia Metals which has risen well on the increased copper price, now making £1,872 profit.

The combined portfolios are £2,967 up on last week, with the buffer between value and cost up to £4,025 and the portfolio value standing at a record £74,134. To give some context, it was less than a month ago on 28th July I reported that the portfolio was at an all time high of £68,162. That's £6,000 rise in less than a month!

I think that deserves a "Woohoo!"


No comments:

Post a Comment